載入...
Infusion-related events during natalizumab: No need for post-infusion monitoring
This retrospective cohort study assessed the timing of infusion-related adverse events (IAEs) during natalizumab (NTZ) administration in well-documented relapsing-remitting multiple sclerosis (RRMS) patients who had received NTZ infusions in our centre between 2006 and 2018. In 225 RRMS patients (14...
Na minha lista:
| 發表在: | Mult Scler |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7575291/ https://ncbi.nlm.nih.gov/pubmed/31237826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458519860415 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|